Trial Profile
Treatment of Ferropenic Anaemia due to acute gastrointestinal bleeding: oral vs intravenous iron therapy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jun 2019
Price :
$35
*
At a glance
- Drugs Ferric carboxymaltose (Primary) ; Ferrous sulfate (Primary)
- Indications Gastrointestinal haemorrhage; Iron deficiency anaemia
- Focus Adverse reactions
- 21 Jun 2019 Status changed from recruiting to completed as per results published in the Alimentary Pharmacology and Therapeutics.
- 14 Jun 2019 Primary endpoint has been met. (Complete response rate (percent of patients who reached Hb levels 12 g/dL or 13 g/dL in women and men respectively))
- 14 Jun 2019 Results published in the Alimentary Pharmacology and Therapeutics